StockDrifts LogoStockDrifts

H&f Corporate Investors X 13F Portfolio

Portfolio Manager
H&f Corporate Investors X LTD
Performance
-11.37% (2026 Q2)
AUM (13F)
$2.80B
# of Holdings
1
Performance Rank
Allocation (Top 20)
100%
Latest filing
Q2 2026

H&f Corporate Investors X LTD Holdings Map

Top 1 H&f Corporate Investors X LTD Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
MDLN
MEDLINE INC
100%70.87M$2.80B
-18.04%(-15.60M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 99.51M shares2026-Q1: 86.47M shares2026-Q2: 70.87M shares
$42.00(-18.90%)
2026-06-30

About H&f Corporate Investors X LTD’s portfolio

H&f Corporate Investors X LTD reports $2.80B in US-listed equity holdings across 1 position in its most recent 13F filing. Its largest disclosed position is MDLN (100.0%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +38.87% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

Trimmed
1
MDLNMEDLINE INC-18.0%

Unlock alerts, watchlists & AI chat

Sign up free to track H&f Corporate Investors X LTD, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from H&f Corporate Investors X LTD’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1901930). View H&f Corporate Investors X LTD’s 13F filings on SEC

More 13F analyses

View all